Bieber Becomes Biopharmaceuticals Development Head At Sandoz

 
• By Dave Wallace

Florian Bieber is to become head of development for Sandoz’ biopharmaceuticals division, after Mark Levick agreed to take up the post of CEO at Alvotech.

RedFigure
Florian Bieber Replaces Mark Levick As Global Head of Development For Sandoz Biopharmaceuticals • Source: Shutterstock

More from Leadership

More from Generics Bulletin